Approval Biosimilar Notice Implicates Millions

Managing Intellectual Property Blog
August 3, 2016

The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.

View Attachment (PDF)